Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Cash from Financing Activities (2023 - 2025)

Ardent Health (ARDT) has 3 years of Cash from Financing Activities data on record, last reported at -$26.9 million in Q3 2025.

  • For Q3 2025, Cash from Financing Activities fell 114.68% year-over-year to -$26.9 million; the TTM value through Sep 2025 reached -$86.9 million, down 419.11%, while the annual FY2024 figure was $24.6 million, 124.1% up from the prior year.
  • Cash from Financing Activities reached -$26.9 million in Q3 2025 per ARDT's latest filing, down from -$25.7 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $183.4 million in Q3 2024 and bottomed at -$119.8 million in Q2 2024.
  • Average Cash from Financing Activities over 3 years is -$9.3 million, with a median of -$20.5 million recorded in 2024.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 867.13% in 2024, then tumbled 114.68% in 2025.
  • A 3-year view of Cash from Financing Activities shows it stood at -$17.9 million in 2023, then dropped by 14.48% to -$20.5 million in 2024, then tumbled by 31.47% to -$26.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$26.9 million in Q3 2025, -$25.7 million in Q2 2025, and -$13.8 million in Q1 2025.